PowerShow.com
  • Help
  • Preferences
  • Sign up
  • Log in
Advanced
Free template

Sirolimus PowerPoint PPT Presentations

Grid List
All Time
All TimeAdded TodayAdded This WeekAdded This Month
Show:
Recommended
RecommendedRelevanceLatestHighest RatedMost Viewed
Sort by:
Featured Presentations
Search Results
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents PowerPoint PPT Presentation
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents - Title: Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents
Title: Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents
| PowerPoint PPT presentation | free to download
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents PowerPoint PPT Presentation
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents - Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents
| PowerPoint PPT presentation | free to download
THE CHANGING FACE OF SIROLIMUS MONITORING PowerPoint PPT Presentation
THE CHANGING FACE OF SIROLIMUS MONITORING - half-life - 62 16h. clearance to liver blood flow. high blood:plasma ratio. 8. Sirolimus ... 2 sirolimus-free. 1 recovery. pooled sample. 10ng/mL added ...
half-life - 62 16h. clearance to liver blood flow. high blood:plasma ratio. 8. Sirolimus ... 2 sirolimus-free. 1 recovery. pooled sample. 10ng/mL added ...
| PowerPoint PPT presentation | free to view
Direct Stenting Using the Sirolimus-Eluting Stent PowerPoint PPT Presentation
Direct Stenting Using the Sirolimus-Eluting Stent - Patients matching those of the SIRIUS trial: de ... Clinical trial results.org. Among patients receiving sirolimus-eluting stents for treatment of single, de ...
Patients matching those of the SIRIUS trial: de ... Clinical trial results.org. Among patients receiving sirolimus-eluting stents for treatment of single, de ...
| PowerPoint PPT presentation | free to download
Alexandru Mischie - Oral sirolimus- A possible treatment for refractory angina pectoris in the elderly PowerPoint PPT Presentation
Alexandru Mischie - Oral sirolimus- A possible treatment for refractory angina pectoris in the elderly - Alexandru Mischie - Oral sirolimus- A possible treatment for refractory angina pectoris in the elderly
Alexandru Mischie - Oral sirolimus- A possible treatment for refractory angina pectoris in the elderly
| PowerPoint PPT presentation | free to download
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial PowerPoint PPT Presentation
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial - SESAMI Trial Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial Presented at The EuroPCR meeting Paris, France May 2006 Presented by Dr. Maurizio ...
SESAMI Trial Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial Presented at The EuroPCR meeting Paris, France May 2006 Presented by Dr. Maurizio ...
| PowerPoint PPT presentation | free to download
The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent PowerPoint PPT Presentation
The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent - The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent Michael Haude, MD
The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent Michael Haude, MD
| PowerPoint PPT presentation | free to download
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study PowerPoint PPT Presentation
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study - Bern-Rotterdam Registry Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large ...
Bern-Rotterdam Registry Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large ...
| PowerPoint PPT presentation | free to download
The Multicenter International LAM Efficacy of Sirolimus Trial (MILES Trial) PowerPoint PPT Presentation
The Multicenter International LAM Efficacy of Sirolimus Trial (MILES Trial) - The Multicenter International LAM Efficacy of Sirolimus Trial (MILES Trial) Frank McCormack, M.D. Scientific Director, The LAM Foundation Professor and Director ...
The Multicenter International LAM Efficacy of Sirolimus Trial (MILES Trial) Frank McCormack, M.D. Scientific Director, The LAM Foundation Professor and Director ...
| PowerPoint PPT presentation | free to download
Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization PowerPoint PPT Presentation
Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization - SIRTAX Trial Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization Presented at American College of Cardiology
SIRTAX Trial Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization Presented at American College of Cardiology
| PowerPoint PPT presentation | free to download
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents PowerPoint PPT Presentation
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents - Background. Restenosis occurring within a drug-eluting stent (DES) is a rare event. Optimal treatment strategies have not been identified and options range from ...
Background. Restenosis occurring within a drug-eluting stent (DES) is a rare event. Optimal treatment strategies have not been identified and options range from ...
| PowerPoint PPT presentation | free to download
The Multicenter International LAM Efficacy of Sirolimus Trial MILES Trial PowerPoint PPT Presentation
The Multicenter International LAM Efficacy of Sirolimus Trial MILES Trial - The Multicenter International LAM Efficacy of Sirolimus Trial ... CAT scan. and ... CAT scans of the chest are done at the beginning, middle and the end. MILES ...
The Multicenter International LAM Efficacy of Sirolimus Trial ... CAT scan. and ... CAT scans of the chest are done at the beginning, middle and the end. MILES ...
| PowerPoint PPT presentation | free to view
Responses to the mTOR Inhibitor Sirolimus in Patients with Malignant PEComa PowerPoint PPT Presentation
Responses to the mTOR Inhibitor Sirolimus in Patients with Malignant PEComa - Responses to the mTOR Inhibitor Sirolimus in Patients with Malignant PEComa Andrew Wagner, Robert Maki, Cristina Antonescu, Christopher Fletcher, Jeffrey Morgan
Responses to the mTOR Inhibitor Sirolimus in Patients with Malignant PEComa Andrew Wagner, Robert Maki, Cristina Antonescu, Christopher Fletcher, Jeffrey Morgan
| PowerPoint PPT presentation | free to download
Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization PowerPoint PPT Presentation
Sirolimus-eluting Stent compared with Paclitaxel-eluting Stent for Coronary Revascularization - 1012 patients with symptomatic coronary artery disease, presence of at least one ... Among patients with coronary artery disease, treatment with the sirolimus ...
1012 patients with symptomatic coronary artery disease, presence of at least one ... Among patients with coronary artery disease, treatment with the sirolimus ...
| PowerPoint PPT presentation | free to download
The Multicenter International LAM Efficacy of Sirolimus Trial MILES Trial PowerPoint PPT Presentation
The Multicenter International LAM Efficacy of Sirolimus Trial MILES Trial - Compared to other diseases that scar the lung, LAM has several assets ... Acne-like lesions. Diarrhea. High blood pressure. Protein in the urine ...
Compared to other diseases that scar the lung, LAM has several assets ... Acne-like lesions. Diarrhea. High blood pressure. Protein in the urine ...
| PowerPoint PPT presentation | free to view
Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization PowerPoint PPT Presentation
Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization - Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous ...
Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous ...
| PowerPoint PPT presentation | free to download
NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent PowerPoint PPT Presentation
NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent - NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent Didier Carri , MD,PhD
NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent Didier Carri , MD,PhD
| PowerPoint PPT presentation | free to download
One Year Post-Exclusivity Adverse Event Review: Sirolimus Pediatric Advisory Committee Meeting November 16, 2006 PowerPoint PPT Presentation
One Year Post-Exclusivity Adverse Event Review: Sirolimus Pediatric Advisory Committee Meeting November 16, 2006 - Indications: Prophylaxis of organ rejection in patients aged 13 years or older ... renal transplant patient on sirolimus, tacrolimus, atorvastatin, ferrous sulfate ...
Indications: Prophylaxis of organ rejection in patients aged 13 years or older ... renal transplant patient on sirolimus, tacrolimus, atorvastatin, ferrous sulfate ...
| PowerPoint PPT presentation | free to view
NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent PowerPoint PPT Presentation
NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent - NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent Didier Carri , MD,PhD
NEXT A Prospective, Randomized Trial Comparing Cre8, a Polymer-Free Stent Eluting Sirolimus, to a Paclitaxel-Eluting Stent Didier Carri , MD,PhD
| PowerPoint PPT presentation | free to download
Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions: PowerPoint PPT Presentation
Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions: - LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions:
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions:
| PowerPoint PPT presentation | free to download
Two-Year Outcomes After Everolimus- or Sirolimus-Eluting Stents in Patients With Coronary Artery Disease in the ISAR-TEST 4 Trial PowerPoint PPT Presentation
Two-Year Outcomes After Everolimus- or Sirolimus-Eluting Stents in Patients With Coronary Artery Disease in the ISAR-TEST 4 Trial - Title: The Detrimental Impact of Chronic Renal Insufficiency Author: jzuccardy Last modified by: Robert Byrne Created Date: 9/24/2010 10:16:56 AM Document ...
Title: The Detrimental Impact of Chronic Renal Insufficiency Author: jzuccardy Last modified by: Robert Byrne Created Date: 9/24/2010 10:16:56 AM Document ...
| PowerPoint PPT presentation | free to download
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: The SIRIUS Trial PowerPoint PPT Presentation
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: The SIRIUS Trial - Lenox Hill Hospital & CRF, New York NY ... Procedural Resource Utilization and Cost. SIRIUS. Initial Hospital Costs $8464 2497 ...
Lenox Hill Hospital & CRF, New York NY ... Procedural Resource Utilization and Cost. SIRIUS. Initial Hospital Costs $8464 2497 ...
| PowerPoint PPT presentation | free to download
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: The SIRIUS Trial PowerPoint PPT Presentation
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: The SIRIUS Trial - ... involvement Total occlusion Ostial location Recent MI Chronic renal ... sidebranch involvement Total occlusion Ostial location Recent ...
... involvement Total occlusion Ostial location Recent MI Chronic renal ... sidebranch involvement Total occlusion Ostial location Recent ...
| PowerPoint PPT presentation | free to download
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents PowerPoint PPT Presentation
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents - CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents
| PowerPoint PPT presentation | free to download
Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent With Durable Polymer: A Randomised, Non-Inferiority Trial PowerPoint PPT Presentation
Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent With Durable Polymer: A Randomised, Non-Inferiority Trial - Biolimus-Eluting Stent With Biodegradable. Polymer Versus Sirolimus-Eluting ... at a concentration of 15.6 g/mm into a biodegradable polymer, polylactic ...
Biolimus-Eluting Stent With Biodegradable. Polymer Versus Sirolimus-Eluting ... at a concentration of 15.6 g/mm into a biodegradable polymer, polylactic ...
| PowerPoint PPT presentation | free to download
Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation PowerPoint PPT Presentation
Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation - Evaluation by OCT of Neointimal Coverage of Sirolimus-Eluting Stent Three Months ... seem to float into the lumen compared with the extra-stent lumen (arrowheads) ...
Evaluation by OCT of Neointimal Coverage of Sirolimus-Eluting Stent Three Months ... seem to float into the lumen compared with the extra-stent lumen (arrowheads) ...
| PowerPoint PPT presentation | free to download
Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation PowerPoint PPT Presentation
Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation - ( B) Length between surfaces of the neointima and each stent strut (NIH thickness) ... ( B) A strut is surrounded by an intracoronary structure with an irregular ...
( B) Length between surfaces of the neointima and each stent strut (NIH thickness) ... ( B) A strut is surrounded by an intracoronary structure with an irregular ...
| PowerPoint PPT presentation | free to download
Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis PowerPoint PPT Presentation
Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis - Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
| PowerPoint PPT presentation | free to download
Comparative Efficacy of Sirolimus in IPEX and IPEXlike Children PowerPoint PPT Presentation
Comparative Efficacy of Sirolimus in IPEX and IPEXlike Children - ... cared for by the Immunology Service at the Children's Hospital ... appreciative of the support of the Leonard Davis Institute of Health Economics and ...
... cared for by the Immunology Service at the Children's Hospital ... appreciative of the support of the Leonard Davis Institute of Health Economics and ...
| PowerPoint PPT presentation | free to view
Clinical Outcomes in Diabetic Patients With Multivessel Disease Treated With Sirolimus or Paclitaxel PowerPoint PPT Presentation
Clinical Outcomes in Diabetic Patients With Multivessel Disease Treated With Sirolimus or Paclitaxel - Clinical Outcomes in Diabetic Patients With Multivessel ... Left circumflex. 39. 42. Left anterior descending. 6. 4. Left main. 0.26. Target lesion location ...
Clinical Outcomes in Diabetic Patients With Multivessel ... Left circumflex. 39. 42. Left anterior descending. 6. 4. Left main. 0.26. Target lesion location ...
| PowerPoint PPT presentation | free to view
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease PowerPoint PPT Presentation
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease - SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
| PowerPoint PPT presentation | free to download
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study PowerPoint PPT Presentation
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study - Bern-Rotterdam Registry Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large ...
Bern-Rotterdam Registry Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large ...
| PowerPoint PPT presentation | free to view
Sirolimus-Eluting Stent Treatment at High-Volume Centers Confers Lower Mortality at 6-Month Follow-Up Results from the German Cypher Registry PowerPoint PPT Presentation
Sirolimus-Eluting Stent Treatment at High-Volume Centers Confers Lower Mortality at 6-Month Follow-Up Results from the German Cypher Registry - University Hospital Bern - Switzerland. Disclosure ... Threshold activity level of 400 PCI annually for hospitals and 75 for operators ...
University Hospital Bern - Switzerland. Disclosure ... Threshold activity level of 400 PCI annually for hospitals and 75 for operators ...
| PowerPoint PPT presentation | free to download
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease PowerPoint PPT Presentation
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease - Title: SO-III TCT 2008 Author: Jens Flensted Lassen Last modified by: Michael Created Date: 10/2/2007 8:23:54 PM Document presentation format: Sk rmshow (4:3)
Title: SO-III TCT 2008 Author: Jens Flensted Lassen Last modified by: Michael Created Date: 10/2/2007 8:23:54 PM Document presentation format: Sk rmshow (4:3)
| PowerPoint PPT presentation | free to download
DES-BTK: A Prospective, Double-Blind Randomized Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease PowerPoint PPT Presentation
DES-BTK: A Prospective, Double-Blind Randomized Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease - Title: Folie 1 Author: sysman Last modified by: psavuser Created Date: 8/16/2010 7:09:41 AM Document presentation format: On-screen Show (4:3) Other titles
Title: Folie 1 Author: sysman Last modified by: psavuser Created Date: 8/16/2010 7:09:41 AM Document presentation format: On-screen Show (4:3) Other titles
| PowerPoint PPT presentation | free to download
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS results of the RRISC trial PowerPoint PPT Presentation
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS results of the RRISC trial - Title: RRISC IVUS Subject: PCI in SVG Author: Agostoni Created Date: 1/1/1601 12:00:00 AM Document presentation format: Presentazione su schermo Company
Title: RRISC IVUS Subject: PCI in SVG Author: Agostoni Created Date: 1/1/1601 12:00:00 AM Document presentation format: Presentazione su schermo Company
| PowerPoint PPT presentation | free to download
AFINITOR 10MG | EVEROLIMUS | MHP PowerPoint PPT Presentation
AFINITOR 10MG | EVEROLIMUS | MHP - Afinitor 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Afinitor 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
ROLIMUS 5MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS PowerPoint PPT Presentation
ROLIMUS 5MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS - Rolimus 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Rolimus 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
ROLIMUS 10MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS PowerPoint PPT Presentation
ROLIMUS 10MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS - Rolimus 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Rolimus 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
EVERMIL 10MG TABLET | EVEROLIMUS | MHP PowerPoint PPT Presentation
EVERMIL 10MG TABLET | EVEROLIMUS | MHP - Evermil 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Evermil 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
EVERMIL 5MG TABLET | EVEROLIMUS | MHP PowerPoint PPT Presentation
EVERMIL 5MG TABLET | EVEROLIMUS | MHP - Evermil 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Evermil 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
EVEROTAS 10MG TABLETS | EVEROLIMUS | MHP PowerPoint PPT Presentation
EVEROTAS 10MG TABLETS | EVEROLIMUS | MHP - Everotas 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Everotas 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
RAPACT 5MG TABLETS | EVEROLIMUS | MHP PowerPoint PPT Presentation
RAPACT 5MG TABLETS | EVEROLIMUS | MHP - Rapact 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Rapact 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
Afinitor 10mgAfinitor 10mg - Anticancer drugs | view uses, side effects and price | MHP PowerPoint PPT Presentation
Afinitor 10mgAfinitor 10mg - Anticancer drugs | view uses, side effects and price | MHP - Afinitor 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor @ MHP
Afinitor 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor @ MHP
| PowerPoint PPT presentation | free to download
EVERTOR 5MG TABLETS | EVEROLIMUS | MHP PowerPoint PPT Presentation
EVERTOR 5MG TABLETS | EVEROLIMUS | MHP - Evertor 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Evertor 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
Infrapopliteal SirolimusEluting Versus Bare Metal Stents for Critical Limb Ischemia: LongTerm Angiog PowerPoint PPT Presentation
Infrapopliteal SirolimusEluting Versus Bare Metal Stents for Critical Limb Ischemia: LongTerm Angiog - Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: ... Compared to bare metal stents, application of sirolimus-eluting ...
Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: ... Compared to bare metal stents, application of sirolimus-eluting ...
| PowerPoint PPT presentation | free to view
 PowerPoint PPT Presentation
- 06/11/2014 OCUK N ROLOJ B L M DALI OLGU SUNUMU Dr. Emek Uyur Yal n Everolimus sirolimusa g re ek bir hidroksi grup ta makta; Suda z nebilirli i ...
06/11/2014 OCUK N ROLOJ B L M DALI OLGU SUNUMU Dr. Emek Uyur Yal n Everolimus sirolimusa g re ek bir hidroksi grup ta makta; Suda z nebilirli i ...
| PowerPoint PPT presentation | free to download
RAPACT 10MG TABLETS | EVEROLIMUS | MHP PowerPoint PPT Presentation
RAPACT 10MG TABLETS | EVEROLIMUS | MHP - Rapact 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
Rapact 10mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor.
| PowerPoint PPT presentation | free to download
Guidelines PowerPoint PPT Presentation
Guidelines - Medical or pharmacokinetic explanations for such observations should be sought and discussed As ... Flecainide, Lithium, Phenytoin, Sirolimus, Tacrolimus ...
Medical or pharmacokinetic explanations for such observations should be sought and discussed As ... Flecainide, Lithium, Phenytoin, Sirolimus, Tacrolimus ...
| PowerPoint PPT presentation | free to download
Large-Scale%20Registry%20Examining%20Safety%20and%20Effectiveness%20of%20Zotarolimus-Eluting%20and%20Sirolimus-Eluting%20Stents%20in%20Patients%20with%20Coronary%20Artery%20Disease PowerPoint PPT Presentation
Large-Scale%20Registry%20Examining%20Safety%20and%20Effectiveness%20of%20Zotarolimus-Eluting%20and%20Sirolimus-Eluting%20Stents%20in%20Patients%20with%20Coronary%20Artery%20Disease - Title: Neointimal Hyperplasia and Peri-stent Remodeling after Sirolimus-eluting or Paclitaxel-eluting Stent Implantation in Diabetic Patients A Randomised ...
Title: Neointimal Hyperplasia and Peri-stent Remodeling after Sirolimus-eluting or Paclitaxel-eluting Stent Implantation in Diabetic Patients A Randomised ...
| PowerPoint PPT presentation | free to download
PROTECT PowerPoint PPT Presentation
PROTECT - PROTECT Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation : a randomised multicentre ...
PROTECT Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation : a randomised multicentre ...
| PowerPoint PPT presentation | free to download
Seung-Jung Park, MD, PhD PowerPoint PPT Presentation
Seung-Jung Park, MD, PhD - Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease
| PowerPoint PPT presentation | free to download
Three-year outcomes according to immunosuppressive regimen PowerPoint PPT Presentation
Three-year outcomes according to immunosuppressive regimen - MMF=mycophenolate mofetil CsA=cyclosporine SRL=sirolimus Meier-Kriesche HU et al. Am J Transplant 2005; 5:2273-2280. * * Title: PowerPoint Presentation Author:
MMF=mycophenolate mofetil CsA=cyclosporine SRL=sirolimus Meier-Kriesche HU et al. Am J Transplant 2005; 5:2273-2280. * * Title: PowerPoint Presentation Author:
| PowerPoint PPT presentation | free to download
 PowerPoint PPT Presentation
- 'Randomized Comparison between Sirolimus (Cypher)/Sirolimus-analogous (Xience; ... Latib, Tiziana C Aranzulla, Alfredo Castelli, Cosmo Godino, Antonio Colombo. ...
'Randomized Comparison between Sirolimus (Cypher)/Sirolimus-analogous (Xience; ... Latib, Tiziana C Aranzulla, Alfredo Castelli, Cosmo Godino, Antonio Colombo. ...
| PowerPoint PPT presentation | free to download
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Maintenance of Long-Term Clinical Benefit with Sirolimus-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction: Three-year results
Maintenance of Long-Term Clinical Benefit with Sirolimus-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction: Three-year results
| PowerPoint PPT presentation | free to download
Seung-Jung Park, MD, PhD PowerPoint PPT Presentation
Seung-Jung Park, MD, PhD - Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions:
Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions:
| PowerPoint PPT presentation | free to download
Page of  


PowerPlugs
PowerPlugs
View by Category
Presentations
  • Photo Slideshows
  • Presentations (free-to-view)
    • Concepts & Trends
    • Entertainment
    • Fashion & Beauty
    • Government & Politics
    • How To, Education & Training
    • Medicine, Science & Technology
    • Other
    • Pets & Animals
    • Products & Services
    • Religious & Philosophical
    • Travel & Places
  • Presentations (pay-to-view)
Products Sold on our sister site CrystalGraphics.com
  • Ultimate Combo for PPT
  • PowerPoint Templates
  • Charts & Diagrams for PPT
  • 3D Character Slides
  • Background Videos for PPT
  • More Products for PPT
PowerPlugs
PowerPlugs
CrystalGraphics
Home About Us Terms and Conditions Privacy Policy Contact Us Send Us Feedback
Copyright 2021 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
sirolimus — Search results on PowerShow.com
Loading...